Literature DB >> 10215750

Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.

F Scaglione1, G Demartini, S Dugnani, M M Arcidiacono, J P Pintucci, F Fraschini.   

Abstract

AIMS: The aim of this study was to determine the potential influence of variables such as the cell content in the fluid, and serum levels, on the concentrations of ceftibuten, cefixime and azithromycin in the middle ear fluid of patients suffering from acute otitis media.
METHODS: This randomized, open study compared the penetration of ceftibuten (9 mg kg(-1) 18 patients), cefixime (8 mg kg(-1), 16 patients) and azithromycin (10 mg kg(-1) 16 patients) into the intracellular and extracellular compartments of middle ear fluid of 50 paediatric patients (aged 8-14 years) with acute otitis media. Middle ear fluid was extracted by tympanocentesis 4, 12 and 24 h after dosing and divided into two fractions: with cells (as collected) (C+) and cell-free (C-). Antibiotics were assayed in C+ and C- samples by h.p.l.c.
RESULTS: Ceftibuten achieved greater penetration into middle ear fluid than cefixime and azithromycin. Higher concentrations of ceftibuten (CTB) and cefixime (CFX) were found in the C- fraction (CTB: 4h 13.3+/-1.86; 12h 4.7+/-1.18; 24h 0.5+/-0.2. CFX: 4h 3.2+/-1.4; 12h 1.5+/-0.5; 24h>(0.1 mgl(-1)) than in the C+ fraction (CTB:4 h 8.4+/-4.3; 12 h 2.88+/-1.19; 24 h 0.3+/-0.27. CFX: 4 h 1.2+/-0.6; 12 h 0.8+/-0.2; 24 h>0.1 mg l(-1)) at the each time point, while the opposite was true for azithromycin (C-: 4 h 0.11+/-0.04; 12 h 0.12+/-0.08; 24 h 0.23+/-0.12. C+: 4 h 0.38+/-0.24; 12 h 0.9+/-0.03; 24 h 1.05+/-0.3 mg l(-1)).
CONCLUSIONS: This study demonstrates that the penetration of antibiotics into the middle ear fluid is influenced by its serum concentrations as well as by the cell content in the fluid. Ceftibuten achieved higher middle ear fluid concentrations than cefixime in C+ and C- fractions at all time points. Both ceftibuten and cefixime concentrations are negatively influenced by the cell content in the fluid. In contrast the concentration of azithromycin to the middle ear fluid is positively influenced by the cell content in the fluid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215750      PMCID: PMC2014225          DOI: 10.1046/j.1365-2125.1999.00887.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.

Authors:  A L Barry; R N Jones
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Rapid high performance liquid chromatographic assay of cephalosporins in biological fluids.

Authors:  C Y Chan; K Chan; G L French
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

Review 3.  The use of antibiotic serum levels to predict concentrations in tissues.

Authors:  D M Ryan; O Cars; B Hoffstedt
Journal:  Scand J Infect Dis       Date:  1986

4.  Principles of tissue penetration of antibiotics.

Authors:  M Barza
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

5.  The pharmacokinetics of azithromycin in human serum and tissues.

Authors:  G Foulds; R M Shepard; R B Johnson
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

Review 6.  Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.

Authors:  A Markham; R N Brogden
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

7.  A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells.

Authors:  F Scaglione; G Demartini; S Dugnani; F Fraschini
Journal:  Chemotherapy       Date:  1993 Nov-Dec       Impact factor: 2.544

8.  Azithromycin concentrations at the sites of pulmonary infection.

Authors:  D R Baldwin; R Wise; J M Andrews; J P Ashby; D Honeybourne
Journal:  Eur Respir J       Date:  1990-09       Impact factor: 16.671

Review 9.  Clinical significance of antibiotic tissue penetration.

Authors:  J J Schentag
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 10.  Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  L R Wiseman; J A Balfour
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

View more
  4 in total

1.  Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.

Authors:  K Allegaert; I Scheers; E Adams; G Brajanoski; V Cossey; B J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

2.  Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo.

Authors:  Franz E Babl; Stephen I Pelton; Zhong Li
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

3.  Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice.

Authors:  Arnab Majhi; Kiran Kundu; Rana Adhikary; Madhubanti Banerjee; Sayantika Mahanti; Anirban Basu; Biswadev Bishayi
Journal:  J Inflamm (Lond)       Date:  2014-02-24       Impact factor: 4.981

Review 4.  What is new in otitis media?

Authors:  Lucien Corbeel
Journal:  Eur J Pediatr       Date:  2007-03-16       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.